trending Market Intelligence /marketintelligence/en/news-insights/trending/3e__qub7bfi0l6a_wuqw2a2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

UK's Sinclair Pharma in preliminary takeover talks with Chinese firms

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


UK's Sinclair Pharma in preliminary takeover talks with Chinese firms

U.K.'s Sinclair Pharma PLC said it received a takeover offer from China Grand Enterprises Inc. and its Huadong Medicine Co. Ltd. unit.

According to the pharmaceutical company, discussions are still at a very early stage with no certainty of an acquisition offer being made.

Under the U.K. Takeover Code, the Chinese firms are required to announce their intentions by Aug. 2.

Following news of the potential transaction, Sinclair Pharma's stock price was up 20.31% to 22 pence as of 3:48 p.m. London Time, July 5.

London-based Sinclair Pharma makes and sells dermatological products worldwide.